Drug-induced agranulocytosis
- 1 July 1997
- journal article
- review article
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 35 (7) , 49-52
- https://doi.org/10.1136/dtb.1997.35749
Abstract
Drug-induced agranulocytosis is a rare, potentially fatal idiosyncratic reaction that can occur unpredictably with a wide variety of drugs when taken in a conventional dose. In this article, we discuss its diagnosis and management and we consider the drugs most commonly involved and ways of minimising risk. We do not consider the dose-related granulocytopenia that commonly complicates treatment with cytotoxic and other myelosuppressant drugs, nor the rarer reaction, aplastic anaemia.Keywords
This publication has 17 references indexed in Scilit:
- Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopeniaAnti-Cancer Drugs, 1996
- Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia?British Journal of Ophthalmology, 1996
- Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendationsJournal of Antimicrobial Chemotherapy, 1993
- Drug‐induced agranulocytosis: prognostic factors in a series of 168 episodesBritish Journal of Haematology, 1991
- Antithyroid Drug–Induced AgranulocytosisArchives of internal medicine (1960), 1990
- From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverThe Journal of Infectious Diseases, 1990
- Empiric antifungal therapy in febrile granulocytopenic patientsThe American Journal of Medicine, 1989
- Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia Study.BMJ, 1988
- Antithyroid DrugsNew England Journal of Medicine, 1984
- Captopril-Associated NeutropeniaArchives of internal medicine (1960), 1983